Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kinuko Mitani

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Scientific Reports|January 27, 2021
Clonal hematopoiesis in adult pure red cell aplasiaNaohito Fujishima, Junki Kohmaru, Souichi Koyota, et al.
Annals of Hematology|April 6, 2020
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myelomaTadao Ishida, Hideo Kimura, Shuji Ozaki, et al.
Annals of Hematology|July 1, 2025
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trialsJun Ho Jang, Kinuko Mitani, Yoshiaki Tomiyama, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 31, 2023
Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysisKaito Harada, Makoto Onizuka, Takehiko Mori, et al.
Annals of Hematology|November 9, 2023
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosisKotaro Shide, Katsuto Takenaka, Akira Kitanaka, et al.
Blood Cancer Journal|July 18, 2023
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk modelKotaro Shide, Katsuto Takenaka, Akira Kitanaka, et al.
Blood Advances|December 22, 2023
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 studyKinuko Mitani, Jong Wook Lee, Jun Ho Jang, et al.
British Journal of Haematology|January 31, 2024
Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registryTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
British Journal of Haematology|April 22, 2025
Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasmsTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan]Shuichi Miyawaki, Nobuhiko Emi, Kinuko Mitani, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Scientific Reports|January 27, 2021
Clonal hematopoiesis in adult pure red cell aplasiaNaohito Fujishima, Junki Kohmaru, Souichi Koyota, et al.
Annals of Hematology|April 6, 2020
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myelomaTadao Ishida, Hideo Kimura, Shuji Ozaki, et al.
Annals of Hematology|July 1, 2025
Predictive factors of romiplostim response in patients with refractory aplastic anemia: data from two clinical trialsJun Ho Jang, Kinuko Mitani, Yoshiaki Tomiyama, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 31, 2023
Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysisKaito Harada, Makoto Onizuka, Takehiko Mori, et al.
Annals of Hematology|November 9, 2023
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosisKotaro Shide, Katsuto Takenaka, Akira Kitanaka, et al.
Blood Cancer Journal|July 18, 2023
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk modelKotaro Shide, Katsuto Takenaka, Akira Kitanaka, et al.
Blood Advances|December 22, 2023
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 studyKinuko Mitani, Jong Wook Lee, Jun Ho Jang, et al.
British Journal of Haematology|January 31, 2024
Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registryTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
British Journal of Haematology|April 22, 2025
Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasmsTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[Clinical course of the disease and the level of WT1 mRNA in 191 patients with acute myeloid leukemia (AML): joint research by 23 institutions in Japan]Shuichi Miyawaki, Nobuhiko Emi, Kinuko Mitani, et al.
Pageof 15